In terms of possible mechanisms, early studies indicated that cannabinoids downregulate VEGF (vascular endothelial growth factor) and angiopoietin-2 (Ang-2) in mouse skin [148] and glioma tumours [149], with additional inhibition of MMP-2 formation described in glioma tumours. Here, ANGPT2 is linked to central nervous system cancer.